Lanean...
The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...
Gorde:
| Argitaratua izan da: | Expert Rev Clin Pharmacol |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/ https://ncbi.nlm.nih.gov/pubmed/23473596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|